PACB Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PACB shares is 319, representing 84.45% of the company's common stock.

SUSQUEHANNA INTERNATIONAL GROUP, LLP, in the last quarter, reduced its stake in PACB by -30.87% restricting it's holding to 529.62 thousand shares of worth nearly $1.99M. GROUP ONE TRADING, L.P. also lessened -52% of the PACB shares from its portfolio, reducing its holding to 193.92 thousand shares of worth $727.18K. JACKSON SQUARE PARTNERS, LLC also shunned PACB shares holding by -25.97% last quarter which brought its holding to 7.18 million shares worth $26.94M.

As per its latest 13F filing, SPIDERROCK ADVISORS, LLC increased its stake in PACB by 100% in the last quarter. The institutional holder raised its holding to 201.53 thousand shares having worth more than $739.63K. DYNAMIC TECHNOLOGY LAB PRIVATE LTD also added 26.44% more shares of PACB to its portfolio, raising its holding to 193.61 thousand shares of worth $726.00K. LPL FINANCIAL LLC also increased its PACB shares holding by 0.26% which brought its holding to 180.65 thousand shares worth $677.45K.

The insider with the most stakes in PACB is HENRY CHRISTIAN O , See Remarks at the company. Additionally, PACB stock is highly held by See Remarks Van Oene Mark and See Remarks Eidel Jeff among others.

Company executives, directors, and other insiders own 9.31% percent of Pacific Biosciences of California, Inc.'s stock. Within the last six months, there have been 5 transaction(s) in which PACB insiders have sold stock, totaling 217.87K shares. Insiders that have sold shares include VAN OENE MARK, KIM SUSAN G., and HENRY CHRISTIAN O.

There have been 0 transaction(s) during the past 6-months in which Pacific Biosciences of California, Inc. insiders have bought stock, totalling 0 shares

Around 7.29M Pacific Biosciences of California, Inc. shares are held by insiders, which represents about 9.31% of PACB stock.

PACB See Remarks, HENRY CHRISTIAN O holds the largest portfolio of the company's shares. PACB shares owned by HENRY total nearly 2.5 million.

SUSQUEHANNA INTERNATIONAL GROUP, LLP is the largest institutional owner in PACB which holds 529.62 thousand shares worth $1.99M or 0.21% of the total PACB shares outstanding followed by SPIDERROCK ADVISORS, LLC with ownership of 201.53 thousand shares representing 0.08% of the PACB ownership. GROUP ONE TRADING, L.P. is the third largest stakeholder with 193.92 thousand shares or 0.08% of the ownership worth more than $727.18K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PACB is concerned, it is a stock which is optionable.

Number of PACB shares short is 56.85M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 294.32M shares of PACB are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PACB has 272.20M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PACB is 6.69.